DEXCOM INC

Insider sale of Dexcom shares shows routine liquidity, not a warning—read how CGM tech, value‑based care, and payer ties keep the company poised for growth.

Dexcom insider buying: CFO’s RSU grant signals confidence, balanced exec trades, and a potential entry point for long‑term investors.